Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advicenne, Alnylam, Argenx, Astrazeneca, Bluebird, Cara, Coherus, Edenbridge, Editas, Everest, GBT, Intra-Cellular, Lannett, Lysogene, Moderna, Novavax, Polarityte, Poseida, Providence, Sorrento, Takeda, Telix, Zogenix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affera, Cytosorbents, Magforce, Vesper, Xeltis, Zynex.

Everest Medicines Ltd. and Providence Therapeutics Holdings Inc.’s COVID-19 vaccine was cleared for inclusion in the World Health Organization’s (WHO) Solidarity Trial Vaccines clinical trial.  

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astellas, Basilea, Biogen, Eisai, Erasca, Glaxosmithkline, Global Blood, Karyopharm, Lyell, Medicago, Medicenna, Merck & Co., Miromatrix, Obseva, Paratek, Pfizer, Seagen, Senhwa, Vir, Xalud, Zai.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: American Regent, Aptose, Biogen, Biontech, Chord, Clarametyx, Claritas, Contrafect, Cytokinetics, Dyadic, Eisai, Emotional, Fibrogen, Freya, Gilead, Helsinn, Hifibio, Jaguar, Ji Xing, Johnson & Johnson, Merck, Moderna, Mylan, Noorik, Novo, Oragenics, Paratek, Pfizer, Sandoz, Sirona, VBL, Vifor, Xediton, Zai.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzamend, Bellerophon, Glycomine, Merck, Mindmed, Navidea, Passage, Ridgeback, Taysha, UCB, Vincerx.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvotech, BMS, Braeburn, Calliditas, Camurus, Daiichi, Innoskel, Mesoblast, Mitotech, Neuvivo, Nkarta, Novavax, Pfizer, Rakuten, Sobi, Verrica, Zai Lab.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaxis, Amplyx, Biomarin, Cadila, Cassiopea, Cava, Cosmo, Hyloris, Iktos, Kineta, Lipidor, Mynd, Pfizer, Providence, Purdue, Skyline, Vaneltix, Vera.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Albireo, Alligator, Apnimed, Applied, Aptinyx, Arcturus, Attralus, Axcella, Celyad, Cullinan, Debiopharm, Denovo, Diffusion, Douglas, Emergent, Ensysce, Fortress, In8bio, Innate, Kodiak, Kura, Kymera, Mallinckrodt, Matinas, Navidea, Nicox, Novaliq, Proqr, Seres, Uniqure, Valneva, Zealand.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Firstkind, Implicity, Roche, Sky Medical Technology.